OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/25/2025
Back to search
Official data from USPTO
GLASEEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
12/26/2025
Trademark type
Word
Nice classes
5
Filing date
04/23/2024
Registration date
01/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2025
Last transaction
12/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
RIBAUDO,MICHELLE RACHEL
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.
Publications
History of USPTO decisions and trademark events.
19 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/12/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2025
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
NPUB
NOTICE OF PUBLICATION
11/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2024
DOCK
ASSIGNED TO EXAMINER
11/04/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/30/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/30/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/30/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/30/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/30/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/17/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/14/2024
Continuous trademark protection
Get notified about every new filing that threatens GLASEEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.